Factors | All | % Affected | % Not affected | RR | P value |
Experience | |||||
Age >24 | 108 | 55.47 | 55.22 | 1.00 | >0.974 |
Experience >4 years | 93 | 43.75 | 55.22 | 0.85 | >0.133 |
Past Olympic Games | 46 | 20.31 | 29.85 | 0.83 | >0.174 |
Past Paralympic Games | 24 | 12.50 | 11.94 | 1.02 | >0.909 |
World Championships | 176 | 89.84 | 91.04 | 0.95 | >0.780 |
Sport type | |||||
Endurance sport | 84 | 39.84 | 49.25 | 0.88 | >0.218 |
Strength sport | 100 | 52.34 | 49.25 | 1.04 | >0.682 |
Team sport | 76 | 33.59 | 49.25 | 0.79 | >0.045* |
Water-based sport | 58 | 28.91 | 31.34 | 0.96 | >0.727 |
Aesthetic sport | 18 | 12.50 | 2.99 | 1.40 | >0.0008* |
Body comp.-aware sport | 71 | 36.72 | 35.82 | 1.01 | >0.901 |
Technical sport | 70 | 40.63 | 25.37 | 1.22 | >0.026* |
HC use | |||||
HC users (AthleteHC) | 113 | 55.47 | 62.69 | 0.90 | >0.326 |
OCP | 66 | 32.81 | 34.33 | 0.97 | >0.758 |
Mirena | 38 | 19.53 | 19.40 | 1.01 | >0.962 |
MC tacking | |||||
Tracking cycle | 82 | 49.22 | 28.36 | 1.34 | >0.0042* |
MC characteristics | |||||
Irregular periods | 36 | 18.75 | 17.91 | 1.02 | >0.885 |
No symptoms | 13 | 1.56 | 16.42 | 0.22 | >0.021* |
1–2 symptoms | 33 | 11.72 | 26.87 | 0.65 | >0.0302* |
3 or more symptoms | 149 | 86.72 | 56.72 | 2.02 | >0.0004* |
Other | |||||
Analgesia use | 90 | 55.47 | 28.36 | 1.45 | >0.0004* |
Female coach | 83 | 47.66 | 32.84 | 1.22 | >0.056 |
*P value ≥0.05
HC, hormonal contraceptive; MC, menstrual cycle; RR, relative risk.